Paolo Tarantino: Terrific TNBC session in Hudson, NY

Paolo Tarantino shared the following on LinkedIn:

“Terrific TNBC session in Hudson, NY.

I had the chance to review current management strategies for stage I TNBC, an extremely common diagnosis (one third of all TNBCs!) for which very little data is available to guide treatment.

Tremendous talks by Drs. Rugo, Traina, and Gadi, highlighting the steady progress in treating TNBC at all stages.

Huge thanks to Maria Theodoulou for the invitation and for organizing this great meeting!”

More posts featuring Paolo Tarantino.

Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.